vs
Side-by-side financial comparison of MEDIFAST INC (MED) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $41.8M, roughly 1.8× Neuronetics, Inc.). On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -36.9%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-6.6M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
MED vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $75.1M | $41.8M |
| Net Profit | — | $-7.2M |
| Gross Margin | 69.4% | 52.0% |
| Operating Margin | -10.4% | -12.1% |
| Net Margin | — | -17.2% |
| Revenue YoY | -36.9% | 85.7% |
| Net Profit YoY | — | 43.2% |
| EPS (diluted) | $-1.64 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $41.8M | ||
| Q3 25 | $89.4M | $37.3M | ||
| Q2 25 | $105.6M | $38.1M | ||
| Q1 25 | $115.7M | $32.0M | ||
| Q4 24 | $119.0M | $22.5M | ||
| Q3 24 | $140.2M | $18.5M | ||
| Q2 24 | $168.6M | $16.4M | ||
| Q1 24 | $174.7M | $17.4M |
| Q4 25 | — | $-7.2M | ||
| Q3 25 | $-2.3M | $-9.0M | ||
| Q2 25 | $2.5M | $-10.1M | ||
| Q1 25 | $-772.0K | $-12.7M | ||
| Q4 24 | — | $-12.7M | ||
| Q3 24 | $1.1M | $-13.3M | ||
| Q2 24 | $-8.2M | $-9.8M | ||
| Q1 24 | $8.3M | $-7.9M |
| Q4 25 | 69.4% | 52.0% | ||
| Q3 25 | 69.5% | 45.9% | ||
| Q2 25 | 72.6% | 46.6% | ||
| Q1 25 | 72.8% | 49.2% | ||
| Q4 24 | 74.1% | 66.2% | ||
| Q3 24 | 75.4% | 75.6% | ||
| Q2 24 | 73.2% | 74.0% | ||
| Q1 24 | 72.8% | 75.1% |
| Q4 25 | -10.4% | -12.1% | ||
| Q3 25 | -4.6% | -19.6% | ||
| Q2 25 | -1.0% | -21.1% | ||
| Q1 25 | -1.1% | -34.4% | ||
| Q4 24 | 0.6% | -51.0% | ||
| Q3 24 | 1.5% | -41.7% | ||
| Q2 24 | -4.7% | -51.7% | ||
| Q1 24 | 4.5% | -39.4% |
| Q4 25 | — | -17.2% | ||
| Q3 25 | -2.5% | -24.3% | ||
| Q2 25 | 2.3% | -26.6% | ||
| Q1 25 | -0.7% | -39.6% | ||
| Q4 24 | — | -56.4% | ||
| Q3 24 | 0.8% | -72.0% | ||
| Q2 24 | -4.8% | -59.8% | ||
| Q1 24 | 4.8% | -45.2% |
| Q4 25 | $-1.64 | $-0.10 | ||
| Q3 25 | $-0.21 | $-0.13 | ||
| Q2 25 | $0.22 | $-0.15 | ||
| Q1 25 | $-0.07 | $-0.21 | ||
| Q4 24 | $0.08 | $-0.34 | ||
| Q3 24 | $0.10 | $-0.44 | ||
| Q2 24 | $-0.75 | $-0.33 | ||
| Q1 24 | $0.76 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $198.9M | $22.4M |
| Total Assets | $248.0M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $28.1M | ||
| Q3 25 | $173.5M | $28.0M | ||
| Q2 25 | $162.7M | $11.0M | ||
| Q1 25 | $164.6M | $20.2M | ||
| Q4 24 | $162.3M | $18.5M | ||
| Q3 24 | $170.0M | $20.9M | ||
| Q2 24 | $163.5M | $42.6M | ||
| Q1 24 | $156.4M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | $198.9M | $22.4M | ||
| Q3 25 | $214.7M | $27.4M | ||
| Q2 25 | $216.0M | $27.1M | ||
| Q1 25 | $211.0M | $35.5M | ||
| Q4 24 | $210.1M | $27.7M | ||
| Q3 24 | $207.3M | $9.4M | ||
| Q2 24 | $205.3M | $19.4M | ||
| Q1 24 | $211.0M | $27.7M |
| Q4 25 | $248.0M | $141.6M | ||
| Q3 25 | $268.2M | $145.5M | ||
| Q2 25 | $269.3M | $134.7M | ||
| Q1 25 | $280.0M | $142.0M | ||
| Q4 24 | $284.2M | $140.9M | ||
| Q3 24 | $291.2M | — | ||
| Q2 24 | $293.5M | $96.8M | ||
| Q1 24 | $302.8M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $908.0K |
| Free Cash FlowOCF − Capex | $-6.6M | $692.0K |
| FCF MarginFCF / Revenue | -8.8% | 1.7% |
| Capex IntensityCapex / Revenue | 1.8% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $908.0K | ||
| Q3 25 | $12.1M | $-785.0K | ||
| Q2 25 | $-3.4M | $-3.5M | ||
| Q1 25 | $3.4M | $-17.0M | ||
| Q4 24 | $-4.9M | $-8.6M | ||
| Q3 24 | $9.1M | $-5.4M | ||
| Q2 24 | $13.1M | $-5.0M | ||
| Q1 24 | $7.3M | $-12.0M |
| Q4 25 | $-6.6M | $692.0K | ||
| Q3 25 | $10.8M | $-899.0K | ||
| Q2 25 | $-4.8M | $-3.8M | ||
| Q1 25 | $1.9M | $-17.2M | ||
| Q4 24 | $-7.2M | $-8.7M | ||
| Q3 24 | $7.7M | $-5.8M | ||
| Q2 24 | $11.1M | $-5.6M | ||
| Q1 24 | $5.4M | $-12.4M |
| Q4 25 | -8.8% | 1.7% | ||
| Q3 25 | 12.0% | -2.4% | ||
| Q2 25 | -4.5% | -9.9% | ||
| Q1 25 | 1.6% | -53.8% | ||
| Q4 24 | -6.1% | -38.6% | ||
| Q3 24 | 5.5% | -31.3% | ||
| Q2 24 | 6.6% | -34.0% | ||
| Q1 24 | 3.1% | -71.1% |
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | 1.5% | 0.3% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 1.3% | 0.7% | ||
| Q4 24 | 1.9% | 0.4% | ||
| Q3 24 | 1.0% | 2.1% | ||
| Q2 24 | 1.1% | 3.7% | ||
| Q1 24 | 1.1% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.